Showing results (21-30 of 21) with videos related to
Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 21 results.
Nature Communications|March 14, 2024
PRMT5 is an actionable therapeutic target in CDK4/6 inhibitor-resistant ER+/RB-deficient breast cancerChang-Ching Lin, Tsung-Cheng Chang, Yunguan Wang, et al.Pageof 3